Table 3

Dosage suppressor screen

Linked genes\Analogue

dhMotC

20

21

27

Average log2 fold ratio treated vs. control


ARO8 MCM6

3.12

3.41

AVO1 ATP19

4.13

2.37

GAA1 ALT1

2.13

2.41

HYS2 SUI2 YJR008W

2.20

2.43

BFR1 MRM1 HIS3

2.01

2.32

2.43

MNN11 YJL181W ATP12 PFD1

1.71

1.98

MTF2 PRP11 SIR2

2.04

1.72

NST1 RHO2

2.03

3.02

SDS22 ACP1

3.09

1.71

1.95

2.60

SPO1 YNL011C YNL010W IDP3 ASI3

3.88

2.15

3.11

YHR162W SOL3 DNA2

2.92

2.99

YML081W DUS1 YML079W CPR3

1.75

2.81

EBS1 UME6 MSS4 YDR210W

2.35

2.43


Syntenic regions enriched after treatment with motuporamines.

Kemmer et al. BMC Microbiology 2009 9:9   doi:10.1186/1471-2180-9-9

Open Data